Artia Global Partners LP
Top Portfolio Positions
49 positions ·
$499,419,986 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| INSM |
INSMED Inc
Healthcare
|
908,412 | $148,543,530 | 29.74% | |
| ABVX |
Abivax S.A.
Healthcare
|
600,747 | $66,893,178 | 13.39% | |
| LLY |
ELI LILLY & Co
Healthcare
|
38,220 | $35,153,609 | 7.04% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
2,013,602 | $24,022,271 | 4.81% | |
| ARGX |
Argenx SE
Healthcare
|
29,739 | $21,716,904 | 4.35% | |
| AZN |
Astrazeneca PLC
Healthcare
|
95,376 | $18,810,054 | 3.77% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
503,936 | $16,130,991 | 3.23% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
162,990 | $13,678,120 | 2.74% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
124,990 | $12,155,277 | 2.43% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
144,376 | $10,841,193 | 2.17% |
Portfolio Trend
14 quarters · across all stocks
Holdings in NAMS
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,130,991 | 503,936 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,678,074 | 503,936 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,541,192 | 194,838 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $494,747 | 27,319 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $1,395,124 | 54,285 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $901,131 | 54,285 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,042,814 | 54,285 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,283,840 | 54,285 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||